Aptar Digital Health and Enable Injections announced a strategic partnership to deliver digital offerings with the enFuse ...

Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse ® system, designed to enhance the patient experience and support adherence. Key ...

Collaboration underscores both companies’ commitment to advancing patient-centric solutions and expanding access to therapies through novel drug delivery technologies Under the terms of the agreement, ...

Incyte (INCY) and Enable announced a new partnership to develop and commercialize specific assets in Incyte’s portfolio, including its investigational mutant calreticulin selective monoclonal antibody ...

CINCINNATI and HUNTSVILLE, Alabama, May 15, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug ...